Taking Novo Nordisk’s https://www.reuters.com/companies/NOVOb.CO” target=”_blank” rel=”noopener”>(NOVOb.CO) new obesity drug may help reduce the risk of heart disease as well as boosting weight loss, according to new research from the United States.
Read More
About The Author
